Lv6
1740 积分 2023-11-13 加入
Anti-tumor efficacy and pre-clinical immunogenicity of IFNα2a-NGR
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
4个月前
已完结
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
5个月前
已完结
IL-12 family cytokines: immunological playmakers
5个月前
已完结
The dual role of IL-27 in CD4+T cells
5个月前
已完结
IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer
5个月前
已完结
Emerging principles of cytokine pharmacology and therapeutics
5个月前
已完结
Interferons α and β in cancer: therapeutic opportunities from new insights
5个月前
已完结
Interleukin-21: a double-edged sword with therapeutic potential
5个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
5个月前
已完结
皖公网安备34019202002308
